NPI: 1720538556 · JACKSONVILLE, FL 32210 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/05/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/05/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 631 | $102K |
| 2019 | 1,947 | $343K |
| 2020 | 12,482 | $1.91M |
| 2021 | 20,640 | $1.78M |
| 2022 | 13,974 | $1.52M |
| 2023 | 7,291 | $281K |
| 2024 | 2,602 | $144K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 22,929 | 1,420 | $2.65M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,915 | 722 | $1.57M |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,014 | 403 | $651K |
| J1756 | Injection, iron sucrose, 1 mg | 4,668 | 747 | $354K |
| A4657 | Syringe, with or without needle, each | 1,582 | 885 | $226K |
| 85048 | 1,249 | 686 | $143K | |
| 85041 | 1,247 | 689 | $141K | |
| 83970 | 644 | 377 | $80K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 609 | 279 | $71K |
| 83540 | 502 | 272 | $59K | |
| 83550 | 502 | 272 | $59K | |
| 82728 | 467 | 257 | $59K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 150 | 62 | $13K |
| 82108 | 70 | 41 | $10K | |
| G0008 | Administration of influenza virus vaccine | 19 | 13 | $3K |